Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
![Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial](https://www.mdpi.com/cancers/cancers-13-04856/article_deploy/html/images/cancers-13-04856-g001.png)
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
![PDF] Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. | Semantic Scholar PDF] Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/062e85a70c6f2d44975de989760becdae280cc49/2-TableI-1.png)
PDF] Reference values for immunoglobulin kappa and lambda light chains and the kappa/lambda ratio in children's serum. | Semantic Scholar
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
![The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12882-020-01771-3/MediaObjects/12882_2020_1771_Fig1_HTML.png)
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
![Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory](https://wardelab.com/wp-content/uploads/2020/06/18_2_4.jpg)
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
![Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121025349-gr1.jpg)
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect
![Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust](https://mft.nhs.uk/app/uploads/2023/01/Myeloma-diagnostic-tool.png)
Demystifying Serum Free Light Chains – a guide for primary care - Manchester University NHS Foundation Trust
![Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png)